RSV-IGIV therapy: a cost/benefit analysis
Gespeichert in:
| Veröffentlicht in: | Pediatrics (Evanston) 1997-09, Vol.100 (3 Pt 1), p.417-418 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 418 |
|---|---|
| container_issue | 3 Pt 1 |
| container_start_page | 417 |
| container_title | Pediatrics (Evanston) |
| container_volume | 100 |
| creator | Thakur, B K Wu, L R Schaeufele, J F |
| description | |
| doi_str_mv | 10.1542/peds.100.3.417 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79304149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79304149</sourcerecordid><originalsourceid>FETCH-LOGICAL-c290t-f5c60ca79b3072ba28d2b07681911f5179033079e8fb14d55b4793352c0271cb3</originalsourceid><addsrcrecordid>eNo9kE1Lw0AQhhdRaq1evQk5CR6SzuxHN-tNSq2BguBHr8vuZoORtInZ5JB_b2qLp2GY530ZHkJuERIUnM4bn4cEARKWcJRnZIqg0phTKc7JFIBhzAHEJbkK4RsAuJB0QiaKAUdIp-Th7X0bZ-tsG3VfvjXN8BiZyNWhm1u_90XZRWZvqiGU4ZpcFKYK_uY0Z-TzefWxfIk3r-ts-bSJHVXQxYVwC3BGKstAUmtomlMLcpGiQiwESgVsvCifFhZ5LoTlUjEmqAMq0Vk2I_fH3qatf3ofOr0rg_NVZfa-7oOWf79zNYLJEXRtHULrC9205c60g0bQBzf64GZcQDM9uhkDd6fm3u58_o-fZLBfVKxckw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79304149</pqid></control><display><type>article</type><title>RSV-IGIV therapy: a cost/benefit analysis</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>Thakur, B K ; Wu, L R ; Schaeufele, J F</creator><creatorcontrib>Thakur, B K ; Wu, L R ; Schaeufele, J F</creatorcontrib><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.100.3.417</identifier><identifier>PMID: 9304108</identifier><language>eng</language><publisher>United States</publisher><subject>Bronchopulmonary Dysplasia - complications ; Cost-Benefit Analysis ; Critical Care - economics ; Hospital Charges ; Hospitalization - economics ; Humans ; Immunoglobulins, Intravenous - administration & dosage ; Immunoglobulins, Intravenous - adverse effects ; Immunoglobulins, Intravenous - economics ; Immunoglobulins, Intravenous - therapeutic use ; Infant ; Infant, Newborn ; Infant, Premature ; Oxygen Inhalation Therapy - economics ; Patient Admission - economics ; Respiration, Artificial - economics ; Respiratory Syncytial Virus Infections - prevention & control ; Respiratory Syncytial Viruses ; Treatment Outcome</subject><ispartof>Pediatrics (Evanston), 1997-09, Vol.100 (3 Pt 1), p.417-418</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c290t-f5c60ca79b3072ba28d2b07681911f5179033079e8fb14d55b4793352c0271cb3</citedby><cites>FETCH-LOGICAL-c290t-f5c60ca79b3072ba28d2b07681911f5179033079e8fb14d55b4793352c0271cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9304108$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thakur, B K</creatorcontrib><creatorcontrib>Wu, L R</creatorcontrib><creatorcontrib>Schaeufele, J F</creatorcontrib><title>RSV-IGIV therapy: a cost/benefit analysis</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><subject>Bronchopulmonary Dysplasia - complications</subject><subject>Cost-Benefit Analysis</subject><subject>Critical Care - economics</subject><subject>Hospital Charges</subject><subject>Hospitalization - economics</subject><subject>Humans</subject><subject>Immunoglobulins, Intravenous - administration & dosage</subject><subject>Immunoglobulins, Intravenous - adverse effects</subject><subject>Immunoglobulins, Intravenous - economics</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Oxygen Inhalation Therapy - economics</subject><subject>Patient Admission - economics</subject><subject>Respiration, Artificial - economics</subject><subject>Respiratory Syncytial Virus Infections - prevention & control</subject><subject>Respiratory Syncytial Viruses</subject><subject>Treatment Outcome</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1Lw0AQhhdRaq1evQk5CR6SzuxHN-tNSq2BguBHr8vuZoORtInZ5JB_b2qLp2GY530ZHkJuERIUnM4bn4cEARKWcJRnZIqg0phTKc7JFIBhzAHEJbkK4RsAuJB0QiaKAUdIp-Th7X0bZ-tsG3VfvjXN8BiZyNWhm1u_90XZRWZvqiGU4ZpcFKYK_uY0Z-TzefWxfIk3r-ts-bSJHVXQxYVwC3BGKstAUmtomlMLcpGiQiwESgVsvCifFhZ5LoTlUjEmqAMq0Vk2I_fH3qatf3ofOr0rg_NVZfa-7oOWf79zNYLJEXRtHULrC9205c60g0bQBzf64GZcQDM9uhkDd6fm3u58_o-fZLBfVKxckw</recordid><startdate>19970901</startdate><enddate>19970901</enddate><creator>Thakur, B K</creator><creator>Wu, L R</creator><creator>Schaeufele, J F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970901</creationdate><title>RSV-IGIV therapy: a cost/benefit analysis</title><author>Thakur, B K ; Wu, L R ; Schaeufele, J F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c290t-f5c60ca79b3072ba28d2b07681911f5179033079e8fb14d55b4793352c0271cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Bronchopulmonary Dysplasia - complications</topic><topic>Cost-Benefit Analysis</topic><topic>Critical Care - economics</topic><topic>Hospital Charges</topic><topic>Hospitalization - economics</topic><topic>Humans</topic><topic>Immunoglobulins, Intravenous - administration & dosage</topic><topic>Immunoglobulins, Intravenous - adverse effects</topic><topic>Immunoglobulins, Intravenous - economics</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Oxygen Inhalation Therapy - economics</topic><topic>Patient Admission - economics</topic><topic>Respiration, Artificial - economics</topic><topic>Respiratory Syncytial Virus Infections - prevention & control</topic><topic>Respiratory Syncytial Viruses</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thakur, B K</creatorcontrib><creatorcontrib>Wu, L R</creatorcontrib><creatorcontrib>Schaeufele, J F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thakur, B K</au><au>Wu, L R</au><au>Schaeufele, J F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RSV-IGIV therapy: a cost/benefit analysis</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>1997-09-01</date><risdate>1997</risdate><volume>100</volume><issue>3 Pt 1</issue><spage>417</spage><epage>418</epage><pages>417-418</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><cop>United States</cop><pmid>9304108</pmid><doi>10.1542/peds.100.3.417</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-4005 |
| ispartof | Pediatrics (Evanston), 1997-09, Vol.100 (3 Pt 1), p.417-418 |
| issn | 0031-4005 1098-4275 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79304149 |
| source | MEDLINE; EZB Electronic Journals Library |
| subjects | Bronchopulmonary Dysplasia - complications Cost-Benefit Analysis Critical Care - economics Hospital Charges Hospitalization - economics Humans Immunoglobulins, Intravenous - administration & dosage Immunoglobulins, Intravenous - adverse effects Immunoglobulins, Intravenous - economics Immunoglobulins, Intravenous - therapeutic use Infant Infant, Newborn Infant, Premature Oxygen Inhalation Therapy - economics Patient Admission - economics Respiration, Artificial - economics Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Viruses Treatment Outcome |
| title | RSV-IGIV therapy: a cost/benefit analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T17%3A14%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RSV-IGIV%20therapy:%20a%20cost/benefit%20analysis&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Thakur,%20B%20K&rft.date=1997-09-01&rft.volume=100&rft.issue=3%20Pt%201&rft.spage=417&rft.epage=418&rft.pages=417-418&rft.issn=0031-4005&rft.eissn=1098-4275&rft_id=info:doi/10.1542/peds.100.3.417&rft_dat=%3Cproquest_cross%3E79304149%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79304149&rft_id=info:pmid/9304108&rfr_iscdi=true |